Vancomycin architecture dependence on the capture efficiency of antibody-modified microbeads by magnetic nanoparticles.
We show that the ability to control the architecture/orientation of vancomycin on the surface of magnetic nanoparticles has a drastic effect on the ability of the nanoparticles to magnetically confine vancomycin-antibody modified polystyrene microbeads.